Activated partial thromboplastin time after heparin removal (aPTT/HR) in a new scheme of anticoagulant monitoring
- 1 June 1982
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 12 (4) , 411-418
- https://doi.org/10.1002/ajh.2830120413
Abstract
Activated partial thromboplastin time after heparin removal (aPTT/HR), a test employing anion exchange chromatography, was devised as an alternative to the prothrombin time after heparin removal (PT/HR) to monitor simultaneous anticoagulation with heparin and coumarins. The potential utility of the aPTT/HR was assessed by performing parallel PTs and aPTTs on 62 consecutive plasmas from coumarin‐treated outpatients. All samples had 0.2 units/ml of heparin added and then removed to see if the maneuver influenced therapeutic group assignment. In no instance did reassignment occur. A conditional Irwin‐Fisher test (P = 0.000604) and a special multinomial trial analysis (P = 0.002) indicated that the aPTT would be at least comparable to the PT for following coumarin antithrombotic prophylaxis. Since the heparin removal procedure had no influence on therapeutic categorization, the same statistical proof could be applied to the relationship between aPTT/HR and PT/HR. This study indicates that the aPTT can be used to monitor all stages of heparin and/or coumarin anticoagulation.Keywords
This publication has 22 references indexed in Scilit:
- Heparin, brain thromboplastin and the insensitivity of the prothrombin time to heparin activityThrombosis Research, 1978
- Synthesis and proof of structure of the new amino acid in prothrombinBiochemical and Biophysical Research Communications, 1975
- A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin TimeNew England Journal of Medicine, 1972
- Treatment of Hemophilia B with a New Clotting-Factor ConcentrateNew England Journal of Medicine, 1969
- Studies on Coumarin Anticoagulant DrugsCirculation, 1968
- Clinical aspects of congenital factor VII deficiencyThe American Journal of Medicine, 1964
- The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these FactorsBritish Journal of Haematology, 1963
- DISAPPEARANCE RATE OF CONCENTRATED PROCONVERTIN EXTRACTS IN CONGENITAL AND ACQUIRED HYPOPROCONVERTINEMIA*Journal of Clinical Investigation, 1960
- THROMBOTEST A NEW METHOD FOR CONTROLLING ANTICOAGULANT THERAPYThe Lancet, 1959
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951